Term
|
Definition
cell membrane; gives the cell structure/integrity; allows things into and out of the cell; formed by hydrophobic lipids(inside layer) and hydrophillic phosphates |
|
|
Term
|
Definition
Housed in the nucleus; contain genes |
|
|
Term
|
Definition
smooth - transport tubes to allow things into and out of the nucleus rough - contains ribosomes |
|
|
Term
|
Definition
Take genetic recipes (genes) and create proteins |
|
|
Term
|
Definition
Takes genetic recipe out of the cells, through ribosome and creates protein |
|
|
Term
|
Definition
Cell bodies with LOTS of ribosomes (black ribosomes with myelination cause gray color) |
|
|
Term
|
Definition
"package" proteins, so they can be transported through/into/out of the cell |
|
|
Term
Anterograde (axonal) Transport |
|
Definition
Cell body to synaptic terminals |
|
|
Term
Retrograde (axonal) Transport |
|
Definition
Synaptic terminals up into cell body |
|
|
Term
|
Definition
Produce energy/fuel for various aspects of cell function; have their own genetic material; hypothesized that they were once free organisms that "infected" other cells |
|
|
Term
Adenosine Triphosphate (ATP) |
|
Definition
Energy molecules produced by the mitochondria |
|
|
Term
|
Definition
-Manifestation of electrical charge in the cell, secondary to chemical messengers crossing the synapse between neurons. - Occurs at the Nodes of Ranvier |
|
|
Term
Action Potential (Breakdown of what happens when) |
|
Definition
A) -70mV; Resting potential; Na+ and Cl- outside of the cell; K+ and giant anions inside A-B) Subthreshold depolarization B) -65mV; Voltage-gated Na+ channels open B-D) Na+ enters the cell C) Voltage-gated K+ channels open; About -20mV C-E) K+ ions leave the cell D) Na+ channels close; +40mV E) K+ channels close E-F) Restoration of Resting Potential due to the sodium-potassium pump |
|
|
Term
Threshold of Excitation (Action Potential) |
|
Definition
-65mV; point when the Na+ channels open, so the action potential process can begin |
|
|
Term
Prerequisites of Action Potential |
|
Definition
1) Diffusion - Spreading from areas of high concentration to low concentration 2) Electromagnetism - Ion = charged particle; Cation = positively charged ion; Anion = negatively charged ion; opposite forces attract; like charges repel; channel opens up, ions act accordingly 3) Sodium-Potassium Pump - clump of proteins embedded in membrane; grabs Na+ and moves them outside cell; pumps K+ in; always active; takes a lot of energy |
|
|
Term
|
Definition
- Chemical that splits into charged particle in water |
|
|
Term
|
Definition
the "dancing" of action potential down the axon, jumping from node to node |
|
|
Term
Perceptions of Stimulation Intensity |
|
Definition
1) Frequency/rate of firing 2) Number of axons involved |
|
|
Term
Advantages of Saltatory Conduction |
|
Definition
1) Faster (~240 mph) since it does not have to travel down every portion of change 2) More economical (fewer places where action potential must occur; thus, requires less energy) |
|
|
Term
|
Definition
- Once conduction reaches the terminal button, it causes the entry of Ca2+ ions to the cell, this eventually causes neurotransmitter release from vesicles in terminal buttons - Ca2+ breaks down bonding molecules that hold vesicles together, causing vesicles to move to the presynaptic membrane - Vesicles then fuse to presynaptic membrane where they fuse with bonding site (fusion pore); causes vesicle to open and spill into the synapse - Neurotransmitters move through the synapse to attach to receptors on the postsynaptic membrane |
|
|
Term
To prevent accumulation of neurotransmitters in the synapse |
|
Definition
1) Reuptake - recycling of neurotransmitters for next action potential 2) Enzymes degrade neurotransmitters |
|
|
Term
|
Definition
(1921) - Experiment involving two anesthetized frogs w/ exposed hearts - Stimulated vagus nerve of one frog causing heart to low; pulled fluid from frog A and injected into frog B - Sense electricity cannot be transferred in such a way, fluid causing slowed heart in frog B must contain chemical signals to cause change |
|
|
Term
Excitatory Post-synaptic Potential (EPSP) |
|
Definition
- Sub threshold depolarization on the postsynaptic membrane due to the entry of sodium ions - Since, action potentials that occur on the dendrites are "graded potentials," they decay as they move along like electricity through a wire; these graded potentials must sum to -65mV to cause action potential in the axon |
|
|
Term
Inhibitory neurotransmitters |
|
Definition
- Land on postsynaptic membrane and open potassium channels, causing "hyperpolarizations" |
|
|
Term
Inhibitory post-synaptic potentials (IPSPs) |
|
Definition
Hyperpolarization of the postsynaptic membrane caused by the exiting of K+ |
|
|
Term
|
Definition
Receptor causing direct opening of ion channel; fast, low-energy |
|
|
Term
|
Definition
Receptor causing indirect opening of ion channel through a chemical process; slower, longer-lasting; MOST receptors to the brain |
|
|
Term
|
Definition
Any drug, chemical, or enzyme that facilitates the post-synaptic action of a neurotransmitter |
|
|
Term
|
Definition
Any substance that hinders the postsynaptic action of a neurotransmitter |
|
|
Term
Steps Involved in Determining Agonist or Antagonist |
|
Definition
"Sure can flow like Coolio. Redman's raps put ninjas down punk" 1) Synthesis of a neurotransmitter 2) Conduction of Action Potential 3) Axoplasmic Flow 4) Leaky Vessicles 5) Entry of Ca2+ into the cell 6) Release of neurotransmitter 7) Reuptake 8) Postsynaptic Receptor 9) Number of Postsynaptic Receptors 10) Enzymatic Destruction 11) Presynaptic Receptors |
|
|
Term
|
Definition
- Occurrs at the neuromuscular junction in relation to skeletal muscles - Occurs at the target organize of the parasympathetic nervous syste -Neurotransmiter at all "1st" synapses in the autonomic nervous system - Consists of acetyl + choline -Enzyme = Choline Acetyl Transferare (ACT) -> breaks down acetylcholine - AchM = Nichonitic - AchM = muscarinic - Acetylcholine reuptake -> Acetylcholine Esterase |
|
|
Term
|
Definition
- Blocks AchN receptors (antagonist) - Paralyzes skeletal muscles - Medically, can be used for localized paralysis |
|
|
Term
|
Definition
- Disease of the thymus that causes blockage of AchN receptors (antagonist; acts like internally produced Curare) - Classic Symptoms: - Muscle Weakness - Drooping Eyelids - Weakness during exercise |
|
|
Term
|
Definition
- Blocks AchM receptors (antagonist) - From extract of a flower native to Columbia - Decreases self-control and causes amnesia - Used for robberies in South America |
|
|
Term
|
Definition
- AchN agonist - LD50 = 60mg - Once used in insecticides |
|
|
Term
|
Definition
- AchM agonist - Found in mushrooms - Hallucinations, odd sensory perceptions, etc. |
|
|
Term
|
Definition
- Agonist - Massive Ach release - Causes paralysis |
|
|
Term
|
Definition
- Inhibit Ach degradation enzyme - Limits reuptake -> allows for buildup of Ach - e.g Physostigmine (treatment for Mysasthenia Gravis), Sevin Dust (insecticide; over aonizes Ach receptors), nerve gases (soman sarin; atropine is often used as an antagonist to combat the effects of nerve gas) |
|
|
Term
|
Definition
- Antagonist - Blocks production of L-Dopa (by preventing action of tyrosine hydroxylase), preventing synthesis of dopamine and norepinephrine - Used in research |
|
|
Term
|
Definition
- Antagonist - Makes vesicles leaky (preventing transmission of norepinephrine) - Once used to treat snake bites and high blood pressure |
|
|
Term
|
Definition
- Antagonist for dopamine, norephinephrine, and serotonin - Enzyme which breaks them down |
|
|
Term
Halperidol; "Haldol," Clorpromazine |
|
Definition
- Blocks postsynaptic receptors (especially dopamine) (antaggonist) - Antipsychotics/neuroleptics - Lead to sedation - Clear up confusion/hallucinations |
|
|
Term
|
Definition
- Blocks reuptake of monoamines (agonist) - Similar drugs used to treat ADHD/ADD |
|
|
Term
|
Definition
- Blocks reuptake of monoamines (agonist) - Also makes neurotransmission reuptake channels run in reverse - Alertness, anti-slep, weight loss |
|
|
Term
|
Definition
- (1939) Ugo Cerletti - Most effective for severe depression - 40% more effective than placebo - 75-80% of people who undergo multiple treatments have a decrease in depression |
|
|
Term
Monoamine Oxidase Inhibitors (MAOI) |
|
Definition
- Inhibits breakdown of all monoamines (5HT, DA, NE) - e.g. Parglyline, Parnate, Nardil - Side Effects: Extreme dietary restruction (build-up of Tyramine) - Drug INteractions - First chemical treatment for depression |
|
|
Term
Tricyclic Antidepressants |
|
Definition
-Imipramine, Amytriptaline, Lodamil, Doexpin - Block reuptake of 5HT and NE - Overdose potential; costly - Unclear why some people have side effects and others don't |
|
|
Term
Selective Serotonin Reuptake Inhibitors |
|
Definition
- Prozac, Zoloft, Celexa, Paxil - In theory, only block reuptake of seretonin but realistically affect other neurotransmitters - Cheaper/safer than other treatments - Used for depression, bulimia, panic disorders, OCD - Side Effects: Anxiety, agitation, insomnia, panic attacks, nausea, headache, GI disorder, sexual disfunction (inability to achieve orgasm), increased suicide risk |
|
|
Term
|
Definition
-NDRI (Norepinephrine Dopamine Reuptake Inhibitors; e.g. Buproprion/Welbutrin) - SNRIs (Serotonin Norepinephrine Reuptake Inhibitors) |
|
|